|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0006826,
umls-concept:C0007102,
umls-concept:C0015737,
umls-concept:C0021853,
umls-concept:C0030705,
umls-concept:C0040085,
umls-concept:C0079419,
umls-concept:C0220901,
umls-concept:C0543467,
umls-concept:C0681804,
umls-concept:C1446468,
umls-concept:C1522609,
umls-concept:C1522673,
umls-concept:C1554112,
umls-concept:C1709701
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-14
|
|
pubmed:abstractText |
To define the value of thymidylate synthase (TS), Ki-67, and p53 as prognostic markers in patients with stage II and III colon carcinoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
241-50
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12525515-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12525515-Colectomy,
pubmed-meshheading:12525515-Colonic Neoplasms,
pubmed-meshheading:12525515-Combined Modality Therapy,
pubmed-meshheading:12525515-Disease-Free Survival,
pubmed-meshheading:12525515-Female,
pubmed-meshheading:12525515-Fluorouracil,
pubmed-meshheading:12525515-Humans,
pubmed-meshheading:12525515-Immunoenzyme Techniques,
pubmed-meshheading:12525515-Ki-67 Antigen,
pubmed-meshheading:12525515-Leucovorin,
pubmed-meshheading:12525515-Male,
pubmed-meshheading:12525515-Middle Aged,
pubmed-meshheading:12525515-Neoplasm Staging,
pubmed-meshheading:12525515-Prognosis,
pubmed-meshheading:12525515-Retrospective Studies,
pubmed-meshheading:12525515-Survival Rate,
pubmed-meshheading:12525515-Thymidylate Synthase,
pubmed-meshheading:12525515-Tumor Markers, Biological,
pubmed-meshheading:12525515-Tumor Suppressor Protein p53
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
|
|
pubmed:affiliation |
Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-2440, USA. allegrac@navmed.nci.nih.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
